SXTP CIK: 1946563

60 Degrees Pharmaceuticals Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY22 – FY25

Assets

(positive)
Change from FY22 to FY25
millions USD
FY22:
1.10
FY23:
7.24
FY24:
5.39
FY25:
4.90
(positive)
Change from FY22 to FY25
millions USD
FY22:
0.20
FY23:
0.54
FY24:
0.37
FY25:
0.47
Total assets
Change from FY22 to FY25
millions USD
FY22:
1.30
FY23:
7.78
FY24:
5.76
FY25:
5.37

Liabilities & Equity

(negative)
Change from FY22 to FY25
millions USD
FY22:
23.9
FY23:
2.84
FY24:
1.66
FY25:
1.84
(negative)
Change from FY22 to FY25
millions USD
FY22:
1.53
FY23:
0.15
FY24:
0.15
FY25:
0.14
(positive)
Change from FY22 to FY25
millions USD
FY22:
−23.6
FY23:
4.87
FY24:
4.04
FY25:
3.46
Total liabilities & equity
Change from FY22 to FY25
millions USD
FY22:
1.87
FY23:
7.86
FY24:
5.84
FY25:
5.45

All amounts in millions USD Data source:SEC EDGAR